Algorithm enables H&E and dissection images to be automatically aligned before...
Algorithm enables H&E and dissection images to be automatically aligned before transferring annotated Regions of Interest to the dissection images

Source: Xyall

Strategic partnership

Plans for an automated, high-precision table-top tumour tissue dissection

Xyall BV, a medtech innovator in molecular pathology, has entered into a multi-year, strategic partnership with Motic, a world leader in microscopy and digital pathology systems. Their goal is to develop an automated, high-precision table-top tumour tissue dissection solution for hospital-based molecular pathology laboratories.

In addition to joint product development, Xyall and Motic have established a reseller and support agreement to accelerate the delivery of these offerings into Chinese and Asian markets. 

 The strategic partnership with Motic adds digital pathology, workflow and scalable capabilities to the Xyall platform and the company expects to have its first table-top products ready for launch in autumn next year. In 2019, Xyall partnered with high-tech engineering company Sioux to bring high precision (medical) robotic solutions and machine learning expertise to their platform.

 Tissue dissection remains a labor-intensive process at risk of error and cross contamination. “Xyall aims to transform the way laboratories carry this out, by delivering an automatic solution with greater accuracy, throughput and quality control,” explained Guido du Pree, Xyall’s CEO.

The combined expertise of our strategic partners creates a dynamic, conviction-led alliance

Guido du Pree

 The company is building a platform to support clinicians and lab managers with faster and more accurate tissue dissection solutions to support them in delivering precision diagnostics. An automated system also makes the most efficient use of existing staffing levels. 

 Alongside the hospital-based system, Xyall intends to launch an industrial, automated tissue dissection solution for high volume (commercial) molecular pathology laboratories. Using the same technology platform, the launch of this large-scale system is planned for spring 2021. 

"We are delighted to join forces with Motic,” said Guido du Pree. “Their knowledge and experience in optics, imaging, pathology workflow, and strong market position in digital pathology, especially in Asia, is an enormous asset and will boost our development and commercialization. The combined expertise of our strategic partners creates a dynamic, conviction-led alliance - to create and drive forward our unique global solutions for both high volume and hospital-based molecular pathology laboratories.”

 Richard Yeung, Motic’s CEO, added: “Motic is not only a trusted global provider of microscopy and digital whole slide imaging solutions, but also operates one of the largest tele-pathology consultation platforms in the world. By teaming up with Xyall and Sioux, we are confident that we have created the synergies needed to build another milestone in digital pathology industry.”

Current practice in tissue dissection involves the pathologist in pen-marking Regions of Interest (ROIs) on Hematoxylin & Eosin (H&E) stained slides. Using visual assessment, lab technicians then translate these ROIs into dissection slides, manually scraping the tissue and placing it in small containers. In view of the worldwide shortage of laboratory technicians, this puts pressure on clinical labs.

Source: Xyall

01.10.2020

Read all latest stories

Related articles

Photo

High-capacity digital image analysis

Spatial statistics extract subvisual features

Spatial analytics offers greater clarity in the assessment of tumours beyond routine microscopic analysis. High-capacity digital image analysis enables new methods of spatial statistics to extract…

Photo

Need for modernisation

Digital pathology: Luxury or necessity?

The anatomical pathologist faces a crisis. Public and private labs suffer increasing caseloads, whilst pathologist numbers diminish for various reasons, including greater cancer prevalence associated…

Photo

Overcoming the barriers to AI in digital pathology

‘You can’t do AI on glass slides’

As Artificial Intelligence continues to impact on the development of digital pathology, potential users are still slow to implement key enabling technologies to harness the benefits, according to Dr…

Related products

Fujifilm – Dynamyx

Pathology

Fujifilm – Dynamyx

FUJIFILM EUROPE GmbH
Hamamatsu Photonics – NanoZoomer S360

Scanner

Hamamatsu Photonics – NanoZoomer S360

Hamamatsu Photonics Europe GmbH
Hamamatsu Photonics – NanoZoomer S60

Scanner

Hamamatsu Photonics – NanoZoomer S60

Hamamatsu Photonics Europe GmbH
Hamamatsu Photonics – NDP.serve3 Image Server Software

Information Technology

Hamamatsu Photonics – NDP.serve3 Image Server Software

Hamamatsu Photonics Europe GmbH